273
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Improved recovery of repeat intoxicated drivers using fingernails and blood spots to monitor alcohol and other substance abuse

, , , &
Pages 9-18 | Received 29 Sep 2015, Accepted 11 May 2016, Published online: 15 Sep 2016

References

  • Anton RF, Youngblood M. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol Clin Exp Res. 2006;11:1878–1883.
  • Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol. 2006;41:431–437.
  • Baumgartner M. Nails: an adequate alternative matrix in forensic toxicology for drugs analysis? Bioanalysis. 2014;6:2189–2191.
  • Bean P, Bean J, Jacobson A, Smith K, Harasymiw J, Campbell T. Alcohol biomarkers as tools to establish risk patterns and guide treatment decisions in repeat intoxicated drivers in Dane County. Alcohol Treat Q. 2013;31:67–77.
  • Bean P, Kay B, Bean J, et al. Recidivism risk of repeat intoxicated drivers monitored with alcohol biomarkers. Alcohol Treat Q. 2014;32:433–444.
  • Bean P, Roska C, Harasymiw J, Pearson J, Kay B, Louks H. Alcohol biomarkers as tools to guide and support decisions about intoxicated driver risk. Traffic Inj Prev. 2009;10:519–527.
  • Berger L, Fendrich M, Jones J, Fuhrmann D, Plate C, Lewis D. Ethyl glucuronide in hair and fingernails as a long-term alcohol biomarker. Addiction. 2014;109:425–431.
  • Bergström J, Helander A, Jones AW. Ethyl glucuronide concentrations in two successive urinary voids from drinking drivers: relationship to creatinine content and blood and urine ethanol concentrations. Forensic Sci Int. 2003;133(1–2):86–94.
  • Bjerre B, Marques P, Selén J, Thorsson U. A Swedish alcohol ignition interlock programme for drink-drivers: Effect on hospital care utilization and sick leave. Addiction. 2007;102:560–570.
  • Bortolotti F, Trettene M, Gottardo R, Bernini M, Ricossa MC, Tagliaro F. Carbohydrate-deficient transferrin (CDT): a reliable indicator of the risk of driving under the influence of alcohol when determined by capillary electrophoresis. Forensic Sci Int. 2007;170(2–3):175–178.
  • Brown R. Drug court effectiveness: a matched cohort study in the Dane County drug treatment court. J Offender Rehabil. 2011;50:191–201.
  • Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004;28:1347–1355.
  • Foti RS, Fisher MB. Assessment of UDP-glucuronosyl-transferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int. 2005;153:109–116.
  • Gjerde H, Sakshaug J, Morland J. Heavy drinking among Norwegian male drunken drivers: a study of gamma-glutamyltransferase. Alcohol Clin Exp Res. 1986;10:209–212.
  • Harasymiw J, Forster I, Bean P. Using the EDAC test to monitor abstinence and relapses during outpatient treatment. J Addict Dis. 2005;24(3):101–113.
  • Harasymiw J, Seaberg J, Bean P. Detection of alcohol misuse using a routine test panel: the early detection of alcohol consumption (EDAC) test. Alcohol Alcohol. 2004;39:329–335.
  • Ingall GB. Alcohol biomarkers. Clin Lab Med. 2012;32:391–406.
  • Jones J, Jones M, Plate C, Lewis D. The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots. Anal Methods. 2011;3:1101–1106.
  • Jones J, Jones M, Plate C, Lewis D, Fendrich M, Berger Fuhrmann L. Liquid chromatography–tandem mass spectrometry assay to detect ethyl glucuronide in human fingernail: comparison to hair and gender differences. Am J Anal Chem. 2012;3:83–91.
  • Kharbouche H, Faouzi M, Sanchez N, et al. Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers. Int J Legal Med. 2012;126:243–250.
  • Khavari K, Farber PD. A profile instrument for the quantification and assessment of alcohol consumption: the Khavari Alcohol Test. J Stud Alcohol Drugs. 1978;39:1525–1539.
  • Korzec A, Bär M, Koeter MW, de Kieviet W. Diagnosing alcoholism in high-risk drinking drivers: comparing different diagnostic procedures with estimated prevalence of hazardous alcohol use. Alcohol Alcohol. 2001;36:594–602.
  • Krumbiegel F, Hastedt M, Tsokos M. Nails are a potential alternative matrix to hair for drug analysis in general unknown screenings by liquid-chromatography quadrupole time-of-flight mass spectrometry. Forensic Sci Med Pathol. 2014;10:496–503.
  • Maenhout TM, Baten G, De Buyzere ML, Delanghe JR. Carbohydrate deficient transferrin in a driver's license regranting program. Alcohol Alcohol. 2012;47:253–260.
  • Maenhout TM, Poll A, Vermassen T, De Buyzere ML, Delanghe JR, and the ROAD Study Group. Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the Recidivism of Alcohol-impaired Driving (ROAD) Study. Addiction. 2014;109:71–78.
  • Marques PR, Hansson T, Isaksson A, et al. Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev. 2011;12(2):136–141.
  • Marques PR, Tippetts S, Allen J, et al. Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives. Addiction. 2010;105:226–239.
  • Marques PR, Tippetts AS, Yegles M. Ethylglucuronide in hair is a top predictor of impaired driving recidivism, alcohol dependence, and a key marker of the highest BAC interlock tests. Traffic Inj Prev. 2014;15:361–369.
  • Mullen J, Ryan SR, Mathias CW, Dougherty DM. Treatment needs of driving while intoxicated offenders: the need for a multimodal approach to treatment. Traffic Inj Prev. 2015;16:637–644.
  • Nanau RM, Neuman MG. Biomolecules and biomarkers used in diagnosis of alcohol drinking and in monitoring therapeutic interventions. Biomolecules. 2015;5:1339–1385.
  • National Center for Statistics and Analysis. Alcohol-impaired driving: 2013 data. (Traffic Safety Facts. DOT HS 812 101). Washington, DC: National Highway Traffic Safety Administration; 2014, December.
  • Ouimet MC, Dongier M, Di Leo I, et al. A randomized controlled trial of brief motivational interviewing in impaired driving recidivists: a 5-year follow-up of traffic offenses and crashes. Alcohol Clin Exp Res. 2013;37:1979–1985.
  • Palmeri A, Pichini S, Pacifici R, Zuccaro P, Lopez A. Drugs in nails: physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet. 2000;38(2):95–110.
  • Piano MR, Tiwari S, Neyoral L, Phillips S. Phosphatidylethanol levels are elevated and correlate strongly with AUDIT scores in young adult binge drinkers. Alcohol Alcohol. 2015;50:519–525.
  • Portman M, Penttilä A, Haukka J, Eriksson P, Alho H, Kuoppasalmi K. Predicting DUI recidivism of male drunken driving: a prospective study of the impact of alcohol markers and previous drunken driving. Drug Alcohol Depend. 2010;106(2–3):186–192.
  • Portman M, Penttilä A, Haukka J, et al. Profile of a drunk driver and risk factors for drunk driving. Findings in roadside testing in the province of Uusimaa in Finland 1990–2008. Forensic Sci Int. 2013;231(1–3):20–27.
  • Schröck A, Hernández Redondo A, Martin Fabritius M, König S, Weinmann W. Phosphatidylethanol (PEth) in blood samples from “driving under the influence” cases as indicator for prolonged excessive alcohol consumption. Int J Legal Med. 2016;130(2):393--400.
  • Snenghi R, Forza G, Favretto D, et al. Underlying substance abuse problems in drunk drivers. Traffic Inj Prev. 2015;16:435–439.
  • Substance Abuse and Mental Health Services Administration. State estimates of persons 18 and older driving under the influence of alcohol or illicit drugs. 2008. Available at: http://www.samhsa.gov/data/2k8/stateDUI/stateDUI.htm. Accessed September 2015.
  • Substance Abuse and Mental Health Services Administration. The role of biomarkers in the treatment of alcohol use disorders, 2012 revision. SAMHSA Advisory. 2012;11(2):1–7.
  • Van Stelle K, Goodrich J, Paltzer J. Treatment Alternatives and Diversion (TAD) Program: Advancing Effective Diversion in Wisconsin. 2014. Available at: https://uwphi.pophealth.wisc.edu/about/staff/van-stelle-kit/tad-2007-2013-data-by-site.pdf. Accessed March 2016.
  • Varga A, Hansson P, Johnson G, Alling C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta. 2000;299:141–150.
  • Winkler M, Skopp G, Alt A, et al. Comparison of direct and indirect alcohol markers with PEth in blood and urine in alcohol dependent inpatients during detoxication. Int J Legal Med. 2013;127:761–768.
  • Wurst FM, Thon N, Aradottir S, et al. Phosphatidylethanol: normalisation during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol. 2010;15:88–95.
  • Wurst FM, Vogel R, Jachau K, et al. Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res. 2003;27:471–476.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.